- Report
- October 2024
- 70 Pages
Japan
From €903EUR$950USD£759GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €903EUR$950USD£759GBP
- Report
- October 2024
- 70 Pages
United States
From €903EUR$950USD£759GBP
- Report
- March 2025
- 10 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2022
- 172 Pages
Global
From €3529EUR$3,712USD£2,965GBP
The Cardiac Rhythm Management (CRM) market is a segment of the cardiovascular devices industry. It includes a range of products and services used to diagnose and treat cardiac arrhythmias, or abnormal heart rhythms. These products include pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and cardiac ablation systems. CRM products are used to monitor and regulate the electrical activity of the heart, helping to restore normal rhythm and improve patient outcomes.
CRM products are used in a variety of clinical settings, including hospitals, clinics, and ambulatory care centers. The market is driven by technological advancements, such as miniaturization of devices and the development of new features, as well as an increasing prevalence of cardiovascular diseases.
Notable companies in the CRM market include Medtronic, Abbott, Boston Scientific, Biotronik, and LivaNova. Show Less Read more